Rebecca Deal1, Charles Frederiks1, Lauren Williams1, Pim B Olthof2, Konstantin Dirscherl3, Xavier Keutgen1, Edie Chan1, Daniel Deziel1, Martin Hertl1, Erik Schadde4,5,6. 1. Department of Surgery - Transplant Surgery, Rush University Medical Center, 1653, W. Congress Pkwy Jelke Building 7th Floor, Chicago, IL, 60612, USA. 2. Department of Experimental Surgery, Academic Medical Center, Amsterdam, The Netherlands. 3. Institute of Physiology, Center for Integrative Human Physiology, University of Zurich, Winterthurerstr. 190, 8057, Zurich, Switzerland. 4. Department of Surgery - Transplant Surgery, Rush University Medical Center, 1653, W. Congress Pkwy Jelke Building 7th Floor, Chicago, IL, 60612, USA. erik.schadde@uzh.ch. 5. Institute of Physiology, Center for Integrative Human Physiology, University of Zurich, Winterthurerstr. 190, 8057, Zurich, Switzerland. erik.schadde@uzh.ch. 6. Cantonal Hospital Winterthur, Brauerstr. 15, 8401, Winterthur, Kanton Zurich, Switzerland. erik.schadde@uzh.ch.
Abstract
BACKGROUND: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) induces more rapid liver growth than portal vein ligation (PVL). Transection of parenchyma in ALPPS may prevent the formation of collaterals between lobes. The aim of this study was to determine if abrogating the formation of collaterals through parenchymal transection impacted growth rate. METHODS: Twelve Yorkshire Landrace pigs were randomized to undergo ALPPS, PVL, or "partial ALPPS" by varying degrees of parenchymal transection. Hepatic volume was measured after 7 days. Portal blood flow and pressure were measured. Portal vein collaterals were examined from epoxy casts. RESULTS: PVL, ALPPS, and partial ALPPS led to volume increases of the RLL by 15.5% (range 3-22), 64% (range 45-76), and 32% (range 18-77), respectively, with significant differences between PVL and ALPPS/partial ALPPS (p < 0.05). In PVL and partial ALPPS, substantial new portal vein collaterals were found. The number of collaterals correlated inversely with the growth rate (p = 0.039). Portal vein pressure was elevated in all models after ligation suggesting hyperflow to the portal vein-supplied lobe (p < 0.05). CONCLUSIONS: These data suggest that liver hypertrophy following PVL is inversely proportional to the development of collaterals. Hypertrophy after ALPPS is likely more rapid due to reduction of collaterals through transection.
BACKGROUND: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) induces more rapid liver growth than portal vein ligation (PVL). Transection of parenchyma in ALPPS may prevent the formation of collaterals between lobes. The aim of this study was to determine if abrogating the formation of collaterals through parenchymal transection impacted growth rate. METHODS: Twelve Yorkshire Landrace pigs were randomized to undergo ALPPS, PVL, or "partial ALPPS" by varying degrees of parenchymal transection. Hepatic volume was measured after 7 days. Portal blood flow and pressure were measured. Portal vein collaterals were examined from epoxy casts. RESULTS: PVL, ALPPS, and partial ALPPS led to volume increases of the RLL by 15.5% (range 3-22), 64% (range 45-76), and 32% (range 18-77), respectively, with significant differences between PVL and ALPPS/partial ALPPS (p < 0.05). In PVL and partial ALPPS, substantial new portal vein collaterals were found. The number of collaterals correlated inversely with the growth rate (p = 0.039). Portal vein pressure was elevated in all models after ligation suggesting hyperflow to the portal vein-supplied lobe (p < 0.05). CONCLUSIONS: These data suggest that liver hypertrophy following PVL is inversely proportional to the development of collaterals. Hypertrophy after ALPPS is likely more rapid due to reduction of collaterals through transection.
Authors: Kristopher P Croome; Shennen A Mao; Jaime M Glorioso; Murli Krishna; Scott L Nyberg; David M Nagorney Journal: HPB (Oxford) Date: 2015-08-02 Impact factor: 3.647
Authors: Héctor M Almau Trenard; Luis E Moulin; Juan M Padín; Pablo Stringa; Gabriel E Gondolesi; Pablo Barros Schelotto Journal: Cir Esp Date: 2014-07-24 Impact factor: 1.653
Authors: Andreas A Schnitzbauer; Sven A Lang; Holger Goessmann; Silvio Nadalin; Janine Baumgart; Stefan A Farkas; Stefan Fichtner-Feigl; Thomas Lorf; Armin Goralcyk; Rüdiger Hörbelt; Alexander Kroemer; Martin Loss; Petra Rümmele; Marcus N Scherer; Winfried Padberg; Alfred Königsrainer; Hauke Lang; Aiman Obed; Hans J Schlitt Journal: Ann Surg Date: 2012-03 Impact factor: 12.969
Authors: Christian Wilms; Lars Mueller; Christian Lenk; Oliver Wittkugel; Knut Helmke; Gerrit Krupski-Berdien; Xavier Rogiers; Dieter C Broering Journal: Ann Surg Date: 2008-05 Impact factor: 12.969
Authors: R Robles; P Parrilla; A López-Conesa; R Brusadin; J de la Peña; M Fuster; J A García-López; E Hernández Journal: Br J Surg Date: 2014-06-19 Impact factor: 6.939
Authors: Long R Jiao; Ana B Fajardo Puerta; Tamara M H Gall; Mikael H Sodergren; Adam E Frampton; Tim Pencavel; Myura Nagendran; Nagy A Habib; Ara Darzi; Madhava Pai; Rob Thomas; Paul Tait Journal: Cancers (Basel) Date: 2019-03-04 Impact factor: 6.639